Fidia S.p.A. (BIT:FDA)
0.1751
-0.0031 (-1.74%)
Nov 21, 2025, 5:35 PM CET
Fidia Employees
Fidia had 159 employees as of December 31, 2024. The number of employees decreased by 34 or -17.62% compared to the previous year.
Employees
159
Change (1Y)
-34
Growth (1Y)
-17.62%
Revenue / Employee
€150,929
Profits / Employee
€15,657
Market Cap
2.61M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 159 | -34 | -17.62% |
| Dec 31, 2023 | 193 | -4 | -2.03% |
| Dec 31, 2022 | 197 | -20 | -9.22% |
| Dec 31, 2021 | 217 | -54 | -19.93% |
| Dec 31, 2020 | 271 | -42 | -13.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Poste Italiane | 125,097 |
| Leonardo S.p.a. | 60,468 |
| Webuild | 43,573 |
| Iveco Group | 36,046 |
| Prysmian | 31,857 |
| Fincantieri | 22,586 |
| Danieli & C. Officine Meccaniche | 10,009 |
| Maire | 9,739 |
Fidia News
- 22 hours ago - Pfizer : FDA Oks PADCEV + Keytruda Combo For Cisplatin-Ineligible Muscle-Invasive Bladder Cancer - Nasdaq
- 1 day ago - Shawn Hunsaker: Guiding New Businesses on an Effective Path with Strategic Vision - CEOWORLD magazine
- 1 day ago - Merck (MRK) Gains FDA Approval for Keytruda in Bladder Cancer Treatment - GuruFocus
- 1 day ago - Merck gets FDA nod for Keytruda and Padcev combo in bladder cancer treatment - Seeking Alpha
- 1 day ago - Merck (MRK) Gains FDA Nod for Keytruda Combination in Bladder Cancer - GuruFocus
- 1 day ago - Elanco (ELAN) Gains FDA Emergency Use Authorization for Credelio CAT - GuruFocus
- 1 day ago - Elanco's Credelio CAT gets FDA Emergency Use Authorization - Seeking Alpha
- 1 day ago - GOP-led states challenging FDA approval of generic abortion pill - The Hill